Warfarin Dosing and Monitoring Protocol

Initial Dosing Strategy

The American College of Cardiology recommends that for outpatients, warfarin therapy should be initiated with 10 mg daily for the first 2 days, followed by dosing based on INR measurements, rather than starting with the estimated maintenance dose 1, 2
For patients who are sufficiently healthy to be treated as outpatients, a loading dose of 10 mg daily for the first 2 days is recommended, followed by INR-guided dosing 1, 2
For elderly patients (≥65 years), those at increased risk of bleeding, or patients expected to have heightened sensitivity to warfarin, the American College of Cardiology suggests using a lower initial dose of 2-5 mg daily 3, 4
When rapid anticoagulation is required, heparin should be given concurrently with warfarin for at least 4 days until the INR has been in the therapeutic range for 2 consecutive days 3, 4

The American College of Cardiology recommends checking INR daily until the therapeutic range has been reached and sustained for 2 consecutive days 3, 4
After initial stabilization, the American College of Cardiology suggests monitoring INR 2-3 times weekly for 1-2 weeks 4
As INR stability improves, the American College of Cardiology recommends gradually reducing monitoring frequency to intervals as long as 4 weeks for stable patients 4

For INR above therapeutic range but <5 without bleeding, the American College of Cardiology recommends reducing or omitting the next dose and resuming at a lower dose when INR approaches the desired range 5
For INR 5-9 without bleeding, the American College of Cardiology suggests omitting 1-2 doses and reinstating at a lower dose when INR returns to the therapeutic range; alternatively, omitting the next dose and giving 1-2.5 mg oral vitamin K if the patient has an increased bleeding risk 5
For INR >9 without bleeding, the American College of Cardiology recommends giving 3-5 mg oral vitamin K 5
For serious bleeding with any INR, the American College of Cardiology suggests administering 5-10 mg IV vitamin K 5, 6

The risk of bleeding increases exponentially with INR values above 3.0 and becomes clinically significant when INR exceeds 5.0 6
Elderly patients have a higher bleeding risk at any given INR level 6
After high-dose vitamin K administration, warfarin resistance may occur, potentially requiring bridging with heparin until vitamin K effects subside 6
Fluctuations in vitamin K intake from diet can affect INR stability 4
Numerous drug interactions can potentiate or inhibit warfarin's effect, requiring more frequent monitoring when starting or stopping other medications 4

The American College of Cardiology defines a major bleed as meeting criteria including bleeding at a critical site, hemodynamic instability, or clinically overt bleeding with significant hemoglobin decrease 7
A significant acute decline in hemoglobin, such as an 8 g/L drop in 24 hours, suggests active bleeding requiring immediate attention, even if it does not meet the strict threshold for major bleeding 7

The American College of Cardiology recommends stopping warfarin immediately in patients with significant bleeding and initiating measures to control the bleeding source, due to the high risk of progression to major bleeding 7
An 8 g/L drop in hemoglobin in 24 hours indicates ongoing blood loss that could rapidly progress to meet major bleeding criteria, necessitating urgent identification of the bleeding source 7
The source of bleeding must be identified urgently, as occult bleeding can be life-threatening 7

If INR is therapeutic but bleeding is occurring, this confirms the bleeding is clinically significant enough to warrant holding warfarin 7
Do not give reversal agents unless the bleeding progresses to major bleeding with hemodynamic instability 7
While warfarin is held, investigate the bleeding source aggressively and assess for hemodynamic stability repeatedly 7

The American College of Cardiology recommends delaying restart of anticoagulation if the source of bleeding has not been identified, the patient is at high risk of rebleeding, or bleeding occurred at a critical site 7
Once the patient is stable and the bleeding source is identified and controlled, warfarin can be restarted at a lower dose than previously prescribed, with continued monitoring of INR 7

Do not continue warfarin simply because the hemoglobin drop doesn't meet the strict threshold for major bleeding, as any significant unexplained hemoglobin drop in a patient recently started on warfarin represents a red flag for bleeding that could rapidly progress 7